Cargando…

Improving Named Entity Recognition for Biomedical and Patent Data Using Bi-LSTM Deep Neural Network Models

The daily exponential increase of biomedical information in scientific literature and patents is a main obstacle to foster advances in biomedical research. A fundamental step hereby is to find key information (named entities) inside these publications applying Biomedical Named Entities Recognition (...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Farag, Aras, Hidir, Hackl-Sommer, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298184/
http://dx.doi.org/10.1007/978-3-030-51310-8_3
Descripción
Sumario:The daily exponential increase of biomedical information in scientific literature and patents is a main obstacle to foster advances in biomedical research. A fundamental step hereby is to find key information (named entities) inside these publications applying Biomedical Named Entities Recognition (BNER). However, BNER is a complex task compared to traditional NER as biomedical named entities often have irregular expressions, employ complex entity structures, and don’t consider well-defined entity boundaries, etc. In this paper, we propose a deep neural network (NN) architecture, namely the bidirectional Long-Short Term Memory (Bi-LSTM) based model for BNER. We present a detailed neural network architecture showing the different NN layers, their interconnections and transformations. Based on existing gold standard datasets, we evaluated and compared several models for identifying biomedical named entities such as chemicals, diseases, drugs, species and genes/proteins. Our deep NN based Bi-LSTM model using word and character level embeddings outperforms CRF and Bi-LSTM using only word level embeddings significantly.